Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case

Sh. A. Zholdasova; V. M. Kemaykin; R. F. Vildanova; A. M. Kuttymuratov; T. R. Sergazina; N. K. Temir; N. B. Dairova

Abstract

Oct 06, 2025 1 0

Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case

Sh. A. Zholdasova ¹ ^* ,

V. M. Kemaykin ¹,

R. F. Vildanova ¹,

A. M. Kuttymuratov ¹,

T. R. Sergazina ¹,

N. K. Temir ¹,

N. B. Dairova ¹

¹ LLP 'National Scientific Oncological Center', Astana, Republic of Kazakhstan^* Corresponding Author

Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), 2025, onmt_A26

Publication date: Oct 06, 2025

Full Text (PDF)

ABSTRACT

---

KEYWORDS

---

CITATION (Vancouver)

Zholdasova SA, Kemaykin VM, Vildanova RF, Kuttymuratov AM, Sergazina TR, Temir NK, et al. Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1):onmt_A26.

Show other citation styles Hide other citation styles

APA

Zholdasova, S. A., Kemaykin, V. M., Vildanova, R. F., Kuttymuratov, A. M., Sergazina, T. R., Temir, N. K., & Dairova, N. B. (2025). Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A26.

Harvard

Zholdasova, S. A., Kemaykin, V. M., Vildanova, R. F., Kuttymuratov, A. M., Sergazina, T. R., Temir, N. K., and Dairova, N. B. (2025). Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A26.

AMA

Zholdasova SA, Kemaykin VM, Vildanova RF, et al. Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1), onmt_A26.

Chicago

Zholdasova, Sh. A., V. M. Kemaykin, R. F. Vildanova, A. M. Kuttymuratov, T. R. Sergazina, N. K. Temir, and N. B. Dairova. "Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case". Oncology, Nuclear Medicine and Transplantology 2025 1 no. Suppl. 1 (2025): onmt_A26.

MLA

Zholdasova, Sh. A. et al. "Efficacy of the Combination of Azacitidine, Venetoclax, and Midostaurin in A Patient With Refractory-Relapsed FLT3-ITD-Positive Acute Myeloid Leukemia: A Clinical Case". Oncology, Nuclear Medicine and Transplantology, vol. 1, no. Suppl. 1, 2025, onmt_A26.

REFERENCES

---

LICENSE

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.